Literature DB >> 30851456

Allogenic tissue-specific decellularized scaffolds promote long-term muscle innervation and functional recovery in a surgical diaphragmatic hernia model.

Caterina Trevisan1, Edoardo Maghin1, Arben Dedja2, Paola Caccin3, Niccolò de Cesare4, Chiara Franzin5, Daniele Boso6, Paola Pesce7, Federico Caicci8, Francesco Boldrin8, Luca Urbani9, Paolo De Coppi10, Michela Pozzobon1, Piero Pavan4, Martina Piccoli11.   

Abstract

Congenital diaphragmatic hernia (CDH) is a neonatal defect in which the diaphragm muscle does not develop properly, thereby raising abdominal organs into the thoracic cavity and impeding lung development and function. Large diaphragmatic defects require correction with prosthetic patches to close the malformation. This treatment leads to a consequent generation of unwelcomed mechanical stress in the repaired diaphragm and hernia recurrences, thereby resulting in high morbidity and significant mortality rates. We proposed a specific diaphragm-derived extracellular matrix (ECM) as a scaffold for the treatment of CDH. To address this strategy, we developed a new surgical CDH mouse model to test the ability of our tissue-specific patch to regenerate damaged diaphragms. Implantation of decellularized diaphragmatic ECM-derived patches demonstrated absence of rejection or hernia recurrence, in contrast to the performance of a commercially available synthetic material. Diaphragm-derived ECM was able to promote the generation of new blood vessels, boost long-term muscle regeneration, and recover host diaphragmatic function. In addition, using a GFP + Schwann cell mouse model, we identified re-innervation of implanted patches. These results demonstrated for the first time that implantation of a tissue-specific biologic scaffold is able to promote a regenerating diaphragm muscle and overcome issues commonly related to the standard use of prosthetic materials. STATEMENT OF SIGNIFICANCE: Large diaphragmatic hernia in paediatric patients require application of artificial patches to close the congenital defect. The use of a muscle-specific decellularized scaffold in substitution of currently used synthetic materials allows new blood vessel growth and nerve regeneration inside the patch, supporting new muscle tissue formation. Furthermore, the presence of a tissue-specific scaffold guaranteed long-term muscle regeneration, improving diaphragm performance to almost complete functional recovery. We believe that diaphragm-derived scaffold will be key player in future pre-clinical studies on large animal models.
Copyright © 2019 Acta Materialia Inc. All rights reserved.

Entities:  

Keywords:  Congenital diaphragmatic hernia; Decellularized tissue; Skeletal muscle; Tissue engineering

Mesh:

Year:  2019        PMID: 30851456     DOI: 10.1016/j.actbio.2019.03.007

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  9 in total

1.  Preclinical Development of Bioengineered Allografts Derived from Decellularized Human Diaphragm.

Authors:  Silvia Barbon; Elena Stocco; Martina Contran; Federico Facchin; Rafael Boscolo-Berto; Silvia Todros; Deborah Sandrin; Filippo Romanato; Piero Pavan; Veronica Macchi; Vincenzo Vindigni; Franco Bassetto; Raffaele De Caro; Andrea Porzionato
Journal:  Biomedicines       Date:  2022-03-22

Review 2.  3D Printing Decellularized Extracellular Matrix to Design Biomimetic Scaffolds for Skeletal Muscle Tissue Engineering.

Authors:  Silvia Baiguera; Costantino Del Gaudio; Paolo Di Nardo; Vittorio Manzari; Felicia Carotenuto; Laura Teodori
Journal:  Biomed Res Int       Date:  2020-11-17       Impact factor: 3.411

3.  Decellularized skeletal muscles display neurotrophic effects in three-dimensional organotypic cultures.

Authors:  Paolo Raffa; Valentina Scattolini; Mattia Francesco Maria Gerli; Silvia Perin; Meihua Cui; Paolo De Coppi; Nicola Elvassore; Paola Caccin; Camilla Luni; Anna Urciuolo
Journal:  Stem Cells Transl Med       Date:  2020-06-24       Impact factor: 6.940

4.  Recurrence of Congenital Diaphragmatic Hernia: Risk Factors, Management, and Future Perspectives.

Authors:  Francesco Macchini; Genny Raffaeli; Ilaria Amodeo; Martina Ichino; José Luis Encinas; Leopoldo Martinez; Lucas Wessel; Giacomo Cavallaro
Journal:  Front Pediatr       Date:  2022-02-09       Impact factor: 3.418

5.  Customized bioreactor enables the production of 3D diaphragmatic constructs influencing matrix remodeling and fibroblast overgrowth.

Authors:  Edoardo Maghin; Eugenia Carraro; Daniele Boso; Arben Dedja; Mattia Giagante; Paola Caccin; Raluca Ana-Maria Barna; Silvia Bresolin; Alice Cani; Giulia Borile; Deborah Sandrin; Filippo Romanato; Francesca Cecchinato; Anna Urciuolo; Dorianna Sandonà; Paolo De Coppi; Piero G Pavan; Martina Piccoli
Journal:  NPJ Regen Med       Date:  2022-04-25

6.  Fabrication and Evaluation of a Xenogeneic Decellularized Nerve-Derived Material: Preclinical Studies of a New Strategy for Nerve Repair.

Authors:  Ting Li; Zhigang Sui; Akira Matsuno; Hirotomo Ten; Kenichi Oyama; Akihiro Ito; Hong Jiang; Xiaomin Ren; Rabia Javed; Lihua Zhang; Qiang Ao
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620

Review 7.  An overview of advanced biocompatible and biomimetic materials for creation of replacement structures in the musculoskeletal systems: focusing on cartilage tissue engineering.

Authors:  Azizeh Rahmani Del Bakhshayesh; Nahideh Asadi; Alireza Alihemmati; Hamid Tayefi Nasrabadi; Azadeh Montaseri; Soodabeh Davaran; Sepideh Saghati; Abolfazl Akbarzadeh; Ali Abedelahi
Journal:  J Biol Eng       Date:  2019-11-13       Impact factor: 4.355

8.  Porcine Decellularized Diaphragm Hydrogel: A New Option for Skeletal Muscle Malformations.

Authors:  Daniele Boso; Eugenia Carraro; Edoardo Maghin; Silvia Todros; Arben Dedja; Monica Giomo; Nicola Elvassore; Paolo De Coppi; Piero Giovanni Pavan; Martina Piccoli
Journal:  Biomedicines       Date:  2021-06-22

Review 9.  Xenogeneic Decellularized Extracellular Matrix-based Biomaterials For Peripheral Nerve Repair and Regeneration.

Authors:  Ting Li; Rabia Javed; Qiang Ao
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.